Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Sunshine Biopharma, Inc. (SBFM) had Cost of Goods Sold of $5.99M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$9.41M |
|
$-1.77M |
|
|
Cost of Goods Sold |
$5.99M |
$3.42M |
|
$11.46M |
|
$-2.05M |
|
$0.07M |
|
$-1.98M |
|
$-1.98M |
|
$-1.77M |
|
$-1.77M |
|
$-1.77M |
|
$-1.77M |
|
$-2.05M |
|
$-0.92M |
|
4.50M |
|
4.50M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$27.85M |
|
$0.64M |
|
$4.11M |
|
$31.97M |
|
$5.57M |
|
-- |
|
$0.71M |
|
$6.28M |
|
$25.67M |
|
$23.19M |
|
$25.68M |
|
4.56M |
|
| Cash Flow Statement Financials | |
$-2.99M |
|
$-0.67M |
|
$3.95M |
|
$9.69M |
|
$10.31M |
|
$0.62M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
36.37% |
|
-21.83% |
|
-21.83% |
|
-- |
|
-21.04% |
|
-18.82% |
|
$-3.15M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.46 |
|
2.62 |
|
34.31 |
|
-6.90% |
|
-7.63% |
|
-5.54% |
|
-6.89% |
|
$5.64 |
|
$-0.70 |
|
$-0.66 |
|